systems cat ary001b Search Results


96
R&D Systems human phospho rtk array kit
Human Phospho Rtk Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human phospho rtk array kit/product/R&D Systems
Average 96 stars, based on 1 article reviews
human phospho rtk array kit - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

98
Bio-Techne corporation proteome profiler human phospho-kinase array kit
Proteome Profiler Human Phospho Kinase Array Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteome profiler human phospho-kinase array kit/product/Bio-Techne corporation
Average 98 stars, based on 1 article reviews
proteome profiler human phospho-kinase array kit - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

95
R&D Systems human phospho receptor tyrosine kinase array kit r d systems
Human Phospho Receptor Tyrosine Kinase Array Kit R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human phospho receptor tyrosine kinase array kit r d systems/product/R&D Systems
Average 95 stars, based on 1 article reviews
human phospho receptor tyrosine kinase array kit r d systems - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
Bio-Techne corporation human phospho-erbb2/her2 (y1248) antibody
Human Phospho Erbb2/Her2 (Y1248) Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human phospho-erbb2/her2 (y1248) antibody/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
human phospho-erbb2/her2 (y1248) antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
R&D Systems pepstatin a aspartic protease inhibitor (#1190/10)
Pepstatin A Aspartic Protease Inhibitor (#1190/10), supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepstatin a aspartic protease inhibitor (#1190/10)/product/R&D Systems
Average 90 stars, based on 1 article reviews
pepstatin a aspartic protease inhibitor (#1190/10) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
RayBiotech inc rtk phosphorylation array 1
Rtk Phosphorylation Array 1, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rtk phosphorylation array 1/product/RayBiotech inc
Average 90 stars, based on 1 article reviews
rtk phosphorylation array 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
R&D Systems resource source identifier proteome profiler mousecytokine array kit r d systems cat
Resource Source Identifier Proteome Profiler Mousecytokine Array Kit R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/resource source identifier proteome profiler mousecytokine array kit r d systems cat/product/R&D Systems
Average 97 stars, based on 1 article reviews
resource source identifier proteome profiler mousecytokine array kit r d systems cat - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

94
R&D Systems proteome profiler human apoptosis array kit
(A) Lethal fraction kinetics following application of 10 μM erlotinib. Cells tested were BT20 + scrambled RNA (SCX), or BT20 + siRNA targeting ELP3, 4, 5, or 6 (ELP KD). Data are mean +/− SD from 3 biological replicate wells. Death rates for each ELP KD compared to SCX (Dunnett’s test). (B-C) CellTrace proliferation dye dilution to determine growth rate of live cells. (B) BT20 cells with scrambled RNA or ELP4 targeted siRNA, untreated (Unt) or given 10 μM erlotinib (ERL). Samples collected prior to or 72 hours after drug application. Representative dye fluorescence distributions from flow cytometry shown based on 3 biological replicate samples with at least 10,000 cells measured per sample. (C) Quantification of cell growth rate from data in (B). Data are mean +/− SD of 3 biological replicate samples. (D) Mcl-1 protein expression in BT20 cells + SCX or + ELP4 siRNA, with or without 10 μM ERL. Blots are representative of 3 biological replicates which all showed similar results. (E) <t>Proteome</t> profiler apoptotic array. Data shown are representative of 3 biological replicate blots from ELP4 siRNA untreated or ELP4 siRNA + 10 μM ERL. (F) Quantification of (D) and (E). Data are mean +/− SD of 3 biological replicate blots. Labelled signals are significantly different in ELP4 KD cells compared to Scrambled RNA cells (t-test with FDR correction). See also figs. S6–S9. For panels (A), (C), and (F): *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.
Proteome Profiler Human Apoptosis Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteome profiler human apoptosis array kit/product/R&D Systems
Average 94 stars, based on 1 article reviews
proteome profiler human apoptosis array kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Illumina Inc illumina oncoarray beadchip
(A) Lethal fraction kinetics following application of 10 μM erlotinib. Cells tested were BT20 + scrambled RNA (SCX), or BT20 + siRNA targeting ELP3, 4, 5, or 6 (ELP KD). Data are mean +/− SD from 3 biological replicate wells. Death rates for each ELP KD compared to SCX (Dunnett’s test). (B-C) CellTrace proliferation dye dilution to determine growth rate of live cells. (B) BT20 cells with scrambled RNA or ELP4 targeted siRNA, untreated (Unt) or given 10 μM erlotinib (ERL). Samples collected prior to or 72 hours after drug application. Representative dye fluorescence distributions from flow cytometry shown based on 3 biological replicate samples with at least 10,000 cells measured per sample. (C) Quantification of cell growth rate from data in (B). Data are mean +/− SD of 3 biological replicate samples. (D) Mcl-1 protein expression in BT20 cells + SCX or + ELP4 siRNA, with or without 10 μM ERL. Blots are representative of 3 biological replicates which all showed similar results. (E) <t>Proteome</t> profiler apoptotic array. Data shown are representative of 3 biological replicate blots from ELP4 siRNA untreated or ELP4 siRNA + 10 μM ERL. (F) Quantification of (D) and (E). Data are mean +/− SD of 3 biological replicate blots. Labelled signals are significantly different in ELP4 KD cells compared to Scrambled RNA cells (t-test with FDR correction). See also figs. S6–S9. For panels (A), (C), and (F): *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.
Illumina Oncoarray Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illumina oncoarray beadchip/product/Illumina Inc
Average 90 stars, based on 1 article reviews
illumina oncoarray beadchip - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega msk1 kinase enzyme system
(A) Lethal fraction kinetics following application of 10 μM erlotinib. Cells tested were BT20 + scrambled RNA (SCX), or BT20 + siRNA targeting ELP3, 4, 5, or 6 (ELP KD). Data are mean +/− SD from 3 biological replicate wells. Death rates for each ELP KD compared to SCX (Dunnett’s test). (B-C) CellTrace proliferation dye dilution to determine growth rate of live cells. (B) BT20 cells with scrambled RNA or ELP4 targeted siRNA, untreated (Unt) or given 10 μM erlotinib (ERL). Samples collected prior to or 72 hours after drug application. Representative dye fluorescence distributions from flow cytometry shown based on 3 biological replicate samples with at least 10,000 cells measured per sample. (C) Quantification of cell growth rate from data in (B). Data are mean +/− SD of 3 biological replicate samples. (D) Mcl-1 protein expression in BT20 cells + SCX or + ELP4 siRNA, with or without 10 μM ERL. Blots are representative of 3 biological replicates which all showed similar results. (E) <t>Proteome</t> profiler apoptotic array. Data shown are representative of 3 biological replicate blots from ELP4 siRNA untreated or ELP4 siRNA + 10 μM ERL. (F) Quantification of (D) and (E). Data are mean +/− SD of 3 biological replicate blots. Labelled signals are significantly different in ELP4 KD cells compared to Scrambled RNA cells (t-test with FDR correction). See also figs. S6–S9. For panels (A), (C), and (F): *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.
Msk1 Kinase Enzyme System, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msk1 kinase enzyme system/product/Promega
Average 90 stars, based on 1 article reviews
msk1 kinase enzyme system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Lethal fraction kinetics following application of 10 μM erlotinib. Cells tested were BT20 + scrambled RNA (SCX), or BT20 + siRNA targeting ELP3, 4, 5, or 6 (ELP KD). Data are mean +/− SD from 3 biological replicate wells. Death rates for each ELP KD compared to SCX (Dunnett’s test). (B-C) CellTrace proliferation dye dilution to determine growth rate of live cells. (B) BT20 cells with scrambled RNA or ELP4 targeted siRNA, untreated (Unt) or given 10 μM erlotinib (ERL). Samples collected prior to or 72 hours after drug application. Representative dye fluorescence distributions from flow cytometry shown based on 3 biological replicate samples with at least 10,000 cells measured per sample. (C) Quantification of cell growth rate from data in (B). Data are mean +/− SD of 3 biological replicate samples. (D) Mcl-1 protein expression in BT20 cells + SCX or + ELP4 siRNA, with or without 10 μM ERL. Blots are representative of 3 biological replicates which all showed similar results. (E) Proteome profiler apoptotic array. Data shown are representative of 3 biological replicate blots from ELP4 siRNA untreated or ELP4 siRNA + 10 μM ERL. (F) Quantification of (D) and (E). Data are mean +/− SD of 3 biological replicate blots. Labelled signals are significantly different in ELP4 KD cells compared to Scrambled RNA cells (t-test with FDR correction). See also figs. S6–S9. For panels (A), (C), and (F): *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.

Journal: Science signaling

Article Title: ELP-dependent expression of Mcl-1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells #

doi: 10.1126/scisignal.abb9820

Figure Lengend Snippet: (A) Lethal fraction kinetics following application of 10 μM erlotinib. Cells tested were BT20 + scrambled RNA (SCX), or BT20 + siRNA targeting ELP3, 4, 5, or 6 (ELP KD). Data are mean +/− SD from 3 biological replicate wells. Death rates for each ELP KD compared to SCX (Dunnett’s test). (B-C) CellTrace proliferation dye dilution to determine growth rate of live cells. (B) BT20 cells with scrambled RNA or ELP4 targeted siRNA, untreated (Unt) or given 10 μM erlotinib (ERL). Samples collected prior to or 72 hours after drug application. Representative dye fluorescence distributions from flow cytometry shown based on 3 biological replicate samples with at least 10,000 cells measured per sample. (C) Quantification of cell growth rate from data in (B). Data are mean +/− SD of 3 biological replicate samples. (D) Mcl-1 protein expression in BT20 cells + SCX or + ELP4 siRNA, with or without 10 μM ERL. Blots are representative of 3 biological replicates which all showed similar results. (E) Proteome profiler apoptotic array. Data shown are representative of 3 biological replicate blots from ELP4 siRNA untreated or ELP4 siRNA + 10 μM ERL. (F) Quantification of (D) and (E). Data are mean +/− SD of 3 biological replicate blots. Labelled signals are significantly different in ELP4 KD cells compared to Scrambled RNA cells (t-test with FDR correction). See also figs. S6–S9. For panels (A), (C), and (F): *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.

Article Snippet: Proteome Profiler Human Apoptosis Array kit (CAT# ARY009), Proteome Profiler Human Phospho-RTK Array Kit (ARY001B), and Pepstatin A aspartic protease inhibitor (#1190/10) were purchased from R&D Systems.

Techniques: Fluorescence, Flow Cytometry, Expressing